PERLEGEN SCIENCES
Perlegen Sciences engages in the discovery and commercialization of genetic variations that provide physicians with information to improve the clinical decision-making process and patient treatment outcomes. Its products include MammaPLUS, a breast cancer risk stratifier and a panel of common genetic variants that stratifies individual genetic and background/clinical risk for those at moderately elevated risk for non-familial breast cancer, as well as impacts the risk for developing invasive breast cancer; and Genotype Browser Website that provides a way to access and view the results of a study of genetic variation in various diverse human populations. Perlegen Sciences, Inc. was founded in 2000 and is based in Mountain View, California.
PERLEGEN SCIENCES
Industry:
Biotechnology Genetics Health Care Pharmaceutical
Founded:
2000-01-01
Address:
Mountain View, California, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
154 M USD
Similar Organizations
Certis Oncology Solutions
Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
KelSie Biotech
KelSie Biotech develops high bioavailability delivery methods to formulate and deliver sensitive active pharmaceutical ingredients.
Current Advisors List
Investors List
CMEA Capital
CMEA Capital investment in Series D - Perlegen Sciences
Sano Ventures
Sano Ventures investment in Series D - Perlegen Sciences
Biofrontier Partners
Biofrontier Partners investment in Series D - Perlegen Sciences
Maverick Ventures
Maverick Ventures investment in Series D - Perlegen Sciences
Zesiger Capital
Zesiger Capital investment in Series D - Perlegen Sciences
SB Life Science
SB Life Science investment in Series D - Perlegen Sciences
BSI SA
BSI SA investment in Series D - Perlegen Sciences
Brookside Capital
Brookside Capital investment in Series D - Perlegen Sciences
Unilever Ventures
Unilever Ventures investment in Series D - Perlegen Sciences
Mizuho Securities
Mizuho Securities investment in Series D - Perlegen Sciences
More informations about "Perlegen Sciences"
Perlegen Sciences - Case - Harvard Business School
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained …See details»
Perlegen Sciences - Funding, Financials, Valuation & Investors
Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes. Search Crunchbase. ... How much funding has …See details»
Perlegen Sciences Inc - Company Profile and News
Perlegen Sciences Inc. is a bio-medical research company. The Company collaborates with partners to rescue or improve drugs and to uncover the genetic causes of diseases. …See details»
Free Perlegen Sciences Case Study Analysis & Solution
Feb 3, 2025 "Perlegen Sciences" Harvard business case study is written by Linda A. Hill, Nicole Tempest. It deals with the challenges in the field of Organizational Behavior. ... Brandeau …See details»
Perlegen Sciences, Inc. - National Center for Biotechnology …
Oct 30, 2009 Perlegen Sciences, Inc. About. Perlegen Sciences closed operations on Oct. 30, 2009. Perlegen was founded in 2000 with the mission of identifying patterns of genetic …See details»
Perlegen Sciences, Inc. Company Profile - Dun & Bradstreet
Perlegen Sciences, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES / SCIENTIFIC RESEARCH …See details»
Perlegen Sciences - Contacts, Employees, Board Members
Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.See details»
Perlegen Sciences Harvard Case Solution & Analysis
Perlegen Sciences Case Solution,Perlegen Sciences Case Analysis, Perlegen Sciences Case Study Solution, As biotech start-up companies involved in the study of the human genome, …See details»
Perlegen Sciences, Inc - VentureRadar
Perlegen Sciences, Inc VentureRadar profile. Find out more about Perlegen Sciences, Inc including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Perlegen Sciences' Recipe for Success - The Scientist …
Jun 5, 2005 It was one of the larger private life sciences financings for the first quarter of 2005 with $74 million from Tokyo-based CSK Venture Capital Co. Ltd. At a time when venture capital funding for some biotech companies can be a …See details»
Perlegen Sciences - Products, Competitors, Financials, Employees ...
Perlegen Sciences is a Mountain View, California-based Healthcare company. Use the CB Insights Platform to explore Perlegen Sciences's full profile. Perlegen Sciences - Products, …See details»
Perlegen Sciences, Inc. | Insights
Oct 30, 2008 Perlegen Sciences, Inc. Industry. In Vitro Diagnostics. Molecular Diagnostics & Genetic Testing; Pharmaceuticals; Biotechnology. Drug Discovery Technologies. Genomics …See details»
Perlegen Sciences, Inc. - ProQuest
A complete list of Perlegen's publicly announced collaborations is listed on the Perlegen website [101]. In 2004, Perlegen performed over 2 billion genotyping assays, including an …See details»
Perlegen Sciences | Harvard Business Publishing Education
As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of highly trained …See details»
Breast Cancer diagnostic markers licensed by Perlegen in …
Oct 16, 2007 Perlegen Sciences, Inc., The University of Cambridge, Cancer Research Technology Ltd (CRT) and its parent organization, Cancer Research UK, announced today …See details»
Perlegen sciences, inc - PubMed
Perlegen sciences, inc Pharmacogenomics. 2005 Jun;6(4):439-42. doi: 10.1517/14622416.6.4.439. ... Perlegen licenses compounds that may benefit from this …See details»
Perlegen Sciences - Tech Stack, Apps, Patents & Trademarks
Feb 2, 2025 Perlegen Sciences uses 7 technology products and services including HTML5, Google Fonts, and Google Analytics, according to G2 Stack. Perlegen Sciences is actively …See details»
Perlegen Signs Its First Big Pharma Deal with ... - GenomeWeb
Sep 27, 2002 Last week, Affymetrix spinoff Perlegen Sciences announced its first commercial engagement, a research collaboration with pharmaceutical giant GlaxoSmithKline to examine …See details»
Perlegen Sciences
Oct 22, 2001 As a biotech start-up company involved in studying human genomes, Perlegen needed to develop an organization that fostered innovation and teamwork among a group of …See details»
75 Years of WMO Science for Action
1 day ago The World Meteorological Organization celebrates 75 years as a specialized agency of the United Nations in 2025, turning science into action for the global good. The enactment …See details»